A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics
- Status
- COMPLETED
- Phase
- PHASE1
Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
- Status
- COMPLETED
- Phase
- PHASE1
Investigation of the Response Relationship of NN5401 in Type 1 Diabetics
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Tolerability of NN9068 in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725
- Status
- COMPLETED
- Phase
- PHASE3
A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver Function
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Two NN1250 Formulations in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Observational Prospective Study on Patients Treated With Norditropin®
- Status
- COMPLETED
- Phase
- N/A